uestion:
Has the patient had a past history of being nonresponsive to an
adequate trial [defined as 8 weeks of no response or a partial response
that plateaued at an unsatisfactory level] of any standard, typical
neuroleptic, while during the trial demonstrating definite
neuroleptic-induced parkinsonism?